Costa Rica vs Jordan: Treatment success rate for patients treated for MDR-TB
Costa Rica
100.0%
in 2019
Jordan
100.0%
in 2022
Costa Rica rank
1st
Jordan rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Costa Rica
- Jordan
How they compare
Costa Rica currently reports 100.0% against 100.0% in Jordan, a difference of 0.0%.
The two have swapped places 1 time across 6 shared years of data; in 2009 it was Costa Rica ahead.
Costa Rica ranks 1st and Jordan ranks 1st of 163 countries.
Costa Rica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 50.0% | 50.0% | Costa Rica |
| 2010s | 81.6% | 63.8% | 17.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Costa Rica or Jordan?
- Costa Rica, at 100.0% against 100.0% in Jordan as of 2019.
- What is the difference in treatment success rate for patients treated for mdr-tb between Costa Rica and Jordan?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Jordan?
- 6 years are reported by both, from 2009 to 2019.
- How do Costa Rica and Jordan rank globally for treatment success rate for patients treated for mdr-tb?
- Costa Rica ranks 1st and Jordan ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.